Multimodal treatment of gastric cancer in the west: Where are we going?

Figure 1 Changing number of patients in three subperiods, stratified according to tumor location and Lauren histotype (GIRCG database).

Figure 2 Images of intestinal (A, C) and diffuse type (B, D) tumors of the stomach. The arrow in D indicates the infiltrative growth of the diffuse histotype in the gastric wall.

Figure 3 Incidence of lymph node metastases according to Lauren histotype stratified for pT stages (GIRCG database).

Figure 4 Survival rate of patients with peritoneal recurrence of gastric cancer.

Figure 5 Proposal of a tailored multimodal approach in resectable non-cardiac gastric cancer. JGCA: Japanese Gastric Cancer Association; NAC: Neoadjuvant chemotherapy; HIPEC: Hyperthermic intraperitoneal chemotherapy.